STOCK TITAN

KNOREX trading suspended over low share price

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

KNOREX Ltd. (KNRX) reported that NYSE American suspended trading in its Class A ordinary shares effective November 11, 2026, and determined to commence delisting proceedings, citing the shares’ low selling price.

The shares remain listed while the appeal is pending, but trading will remain suspended during the appeal. KNOREX intends to appeal by requesting a hearing; the request for review must be made by November 18, 2026. The company also currently intends to seek a reverse stock split to support its appeal and continued listing. It said a reverse split would not, by itself, change shareholders’ percentage ownership, but cautioned that continued listing and regaining compliance are not assured.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointNYSE American trading suspension: effective November 11, 2026.
Trading suspension effective date November 11, 2026 NYSE American Class A ordinary shares
Review request deadline November 18, 2026 Deadline to request review of the delisting determination
delisting proceedings regulatory
"determined to commence proceedings to delist the Class A ordinary shares"
Delisting proceedings are the formal steps taken to remove a company’s shares from a stock exchange, either because the company chose to leave or failed to meet rules like minimum share price, reporting or solvency requirements. For investors this matters because removal usually cuts trading access and liquidity, can sharply lower the share price, and makes it harder to buy, sell or get transparent information — similar to a product being pulled off supermarket shelves.
Listings Qualifications Panel regulatory
"review of the delisting determination by the Listings Qualifications Panel"
A listings qualifications panel is a committee at a stock exchange or regulatory body that reviews whether a company continues to meet the exchange’s rules on finances, disclosure and governance. For investors it matters because the panel can require corrective actions, impose trading limits, or remove a stock from the exchange—moves that directly affect a company’s liquidity, market price and investors’ ability to buy or sell shares, like a quality-control inspector deciding if a product stays on the shelf.
reverse stock split technical
"intends to seek to effect a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
continued listing standards regulatory
"regain compliance with the continued listing standards of NYSE American"
Ongoing rules a stock exchange requires a listed company to meet to keep its shares trading publicly, such as minimum share price, market value, timely financial reports, and governance practices. Think of it as a membership checklist for a club: falling short can lead to warnings or removal from the exchange, which can sharply reduce liquidity, investor confidence, and a stock’s value. Investors watch these standards to gauge regulatory risk and the stability of their holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why was KNRX trading suspended?

NYSE American suspended trading in KNRX’s Class A ordinary shares effective November 11, 2026, citing their low selling price under Section 1003(f)(v) of the NYSE American Company Guide. The Exchange also determined to commence delisting proceedings.

When must KNRX request review of the delisting decision?

The request for review must be made no later than November 18, 2026. KNOREX intends to appeal by requesting a hearing before the Listings Qualifications Panel.

Will KNRX shares be delisted from NYSE American?

The Class A ordinary shares remain listed while the appeal is pending, although trading is suspended during the appeal. NYSE American said it will apply to the SEC to delist the shares after applicable procedures, including any appeal, are complete.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number 001-42862

 

KNOREX Ltd.

(Exact name of registrant as specified in its charter)

 

21 Merchant Road, #04-01

Singapore 058267

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 
 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

 

On November 11, 2026, KNOREX Ltd. (the “Company”) was notified by NYSE American LLC (the “Exchange”) that the Exchange’s staff has suspended trading in the Company’s Class A ordinary shares, effective immediately, and has determined to commence proceedings to delist the Class A ordinary shares of the Company (the “Notice”). The Exchange cited Section 1003(f)(v) of the NYSE American Company Guide, based on the low selling price of the Class A ordinary shares.

 

NYSE American publicly announced its decision on November 11, 2026. NYSE American will apply to the U.S. Securities and Exchange Commission (the “SEC”) to delist the Company’s Class A ordinary shares upon completion of applicable procedures, including any appeal by the Company of NYSE Regulation’s decision.

 

According to the Notice, the Company has the right to a review of the delisting determination by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, provided that the Company’s request for such a review must be made by no later than November 18, 2026.

 

The Company intends to appeal the staff’s determination by requesting a hearing before a Listing Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, as permitted under Section 1203 of the NYSE American Company Guide. During the appeal process, the ordinary shares will remain suspended from trading on the NYSE American. The Class A ordinary shares remain listed on the NYSE American while the appeal is pending. The Exchange has stated that it will apply to the Securities and Exchange Commission to delist the ordinary shares only upon completion of all applicable procedures, including any appeal by the Company. The Company currently intends to seek to effect a reverse stock split as a tool to support its appeal and continued listing. A reverse stock split would not, by itself, change shareholders’ percentage ownership of the Company. There can be no assurance, however, that the Panel will grant the Company’s request for continued listing, or that the Company will be able to regain compliance with the continued listing standards of NYSE American.

 

The Company furnishes this report on Form 6-K to satisfy its obligation under the NYSE American Company Guide to publicly disclose the receipt of the Notice and the basis for the Exchange’s staff determination to commence proceedings to delist the Company’s Class A ordinary shares from NYSE American.

 

Forward-Looking Statements

 

This report contains certain forward-looking statements which reflect the Company’s intent, beliefs or current expectations about the future and can be recognized by the use of words such as “intends,” “expects,” “will,” “anticipate,” or words of similar meaning. These forward-looking statements are not guarantees of any future performance and are necessarily estimates reflecting the best judgment of the senior management of the Company and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. As a consequence, these forward-looking statements should be considered in light of various important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements, which include, without limitation, the risk factors set forth in the Company’s annual report on Form 20-F and other filings with the SEC. The Company cannot guarantee that any forward-looking statement will be realized, although it believes it has been prudent in its plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. The Company undertakes no obligation to update publicly or release any revisions to these forward-looking statements to reflect events or circumstances or to reflect the occurrence of unanticipated events, except as required by applicable law.

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release dated November 12, 2026

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  KNOREX Ltd.
     
Date: November 13, 2026 By: /s/ Khar Heng Choo
  Name: Khar Heng Choo
  Title: Chairman of the Board of Directors
and Chief Executive Officer

 

 

 

Exhibit 99.1

 

KNOREX Ltd. Announces Receipt of NYSE American Notice of Trading Suspension and Delisting

 

ALLEN, Texas and SINGAPORE – November 12, 2026 – KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven cross-channel programmatic advertising solutions, announced that on November 11, 2026, it was notified by NYSE American LLC (the “Exchange”) that the Exchange’s staff has suspended trading in the Company’s Class A ordinary shares, effective immediately, and has determined to commence proceedings to delist the Class A ordinary shares of the Company (the “Notice”). The Exchange cited Section 1003(f)(v) of the NYSE American Company Guide, based on the low selling price of the Class A ordinary shares.

 

According to the Notice, the Company has the right to a review of the delisting determination by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, provided that the Company’s request for such a review must be made by no later than November 18, 2026.

 

The Company intends to appeal the staff’s determination by requesting a hearing before a Listing Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, as permitted under Section 1203 of the NYSE American Company Guide. During the appeal process, the ordinary shares will remain suspended from trading on the NYSE American. The Class A ordinary shares remain listed on the NYSE American while the appeal is pending. The Exchange has stated that it will apply to the Securities and Exchange Commission to delist the ordinary shares only upon completion of all applicable procedures, including any appeal by the Company. The Company currently intends to seek to effect a reverse stock split as a tool to support its appeal and continued listing. A reverse stock split would not, by itself, change shareholders’ percentage ownership of the Company.

 

The Company remains focused on its business operations and remains committed to maintaining high standards of corporate governance, compliance, and transparency. The Company will provide further updates as appropriate.

 

About KNOREX Ltd.

 

Founded in 2009, KNOREX Ltd. is a B2B technology company that provides AI-driven marketing automation and digital advertising solutions to help businesses simplify and optimize their digital marketing execution. The Company’s flagship platform, KNOREX XPOsm, is an AI-powered, cloud-based advertising technology platform that enables marketers to efficiently plan, execute, and optimize cross-channel ad campaigns across a diverse range of digital media, including social media, search, CTV/OTT, video, audio, display, native, and DOOH advertising.

 

By leveraging advanced AI/ML-driven automation, KNOREX XPO allows advertisers to enhance campaign performance, reduce wasted ad spend, and scale their marketing efforts while maintaining efficiency and transparency. The platform is designed to address the growing complexity in digital marketing by centralizing campaign execution and analytics into a unified, data-driven workflow.

 

KNOREX serves global enterprises, agencies, and brands across multiple industries, helping them navigate the rapidly evolving digital advertising landscape with automated, intelligent, and data-driven solutions. The Company has operations in the United States, Vietnam, India, Malaysia, and Singapore.

 

For additional information, please visit www.knorex.com.

 

FORWARD-LOOKING STATEMENTS

 

Certain statements in this press release are “forward-looking statements” as defined under the federal securities laws, including, but not limited to, the Company’s expectations regarding the completion, timing and size of the proposed Offering and statements regarding the use of proceeds from the sale of the Company’s shares in the Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “believe,” “plan,” “expect,” “intend,” “should,” “seek,” “estimate,” “will,” “aim,” and “anticipate,” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

 

Contacts

 

Crescendo Communications, LLC

212-671-1020

KNRX@crescendo-ir.com

 

 

Filing Exhibits & Attachments

1 document

Keep reading